Insiders · Profile

Gassert Chad

SVP - CORP. DEV. & STRATEGY at ANI PHARMACEUTICALS. Filing since 18 Mar 2022. CIK 0001871002

Company
Date
Role
Action
Shares
Amount
Of holding
13 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sold at will
94
$8.27K
0.1%
12 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sold at will
14,642
$1.30M
8.5%
15 Aug 2025
SVP - CORP. DEV. & STRATEGY
Sold at will
20,000
$1.74M
10.4%
1 Jul 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.27M
9.4%
3 Jun 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.29M
8.6%
1 May 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.33M
7.9%
1 Apr 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.35M
7.3%
11 Mar 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.32M
6.8%
2 Oct 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.13M
6.4%
1 Sep 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.29M
6.0%
1 Aug 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.02M
5.7%
3 Jul 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.07M
5.4%
22 Jun 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan
20,000
$1.03M
5.1%
21 Mar 2022
SVP - CORP. DEV. & STRATEGY
Bought
5,000
$139.34K
1.3%
18 Mar 2022
SVP - CORP. DEV. & STRATEGY
Bought
5,000
$135.74K
1.3%
15 decisions on file.